Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles

FHS
April 5, 2024
11:00 am

Recombinant adeno-associated virus (rAAV)-based genetic applications to treat human diseases.

Five Companies Sign Agreement to Participate in National Health Data-Sharing Network

WASHINGTON — Five healthcare companies took another step toward becoming part of a nationwide network to exchange patient health information on Tuesday. “I feel like

December 13, 2023

Long COVID linked to higher risk of erectile dysfunction, new study finds

The risk of developing erectile dysfunction (ED) following a diagnosis of long coronavirus disease (COVID) compared to acute COVID.

June 4, 2024

A mysterious anti ‘Big Pharma’ bus is barnstorming swing states

WASHINGTON — The wheels on a big red bus emblazoned with anti-pharmaceutical industry messaging are going ’round and ’round all through the nation’s electoral battlegrounds,

September 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.